Table 5:
No | mRNA NM_032383.5 | Amino Acid NP_115759.2 | Exon/Intron | Variant Type 1 | Ethnic Background 2 | References and Footnotes |
---|---|---|---|---|---|---|
1 | c.-2993_217+692del 3 | - | 5’UTR Intron 1 | Indel | Central Puerto Rican | (Anikster et al., 2001; Torres-Serrant et al., 2010) 3,4 |
2 | c.15C>G | p.Tyr5* | Exon 1 | Nonsense | Dutch, German | novel 5,6 |
3 | c.87dupG | p.Arg30Alafs*2 | Exon 1 | Frameshift | Japanese | (Saito et al., 2019) |
4 | c.319C>T | p.Arg107* | Exon 1 | Nonsense | Japanese | (Okamura et al., 2019) 7 |
5 | c.437_439delGAG | p.Gly146del | Exon 1 | Indel | Japanese | (Okamura et al., 2019) 7,8 |
6 | c.712+2T>C | IVS2+2 | Intron 2 | Splice site | Chinese | (A. Wei et al., 2016) 7 |
7 | c.726_727insTGCCTTACATC | p.Ile243Cysfs*41 | Exon 3 | Indel | Puerto Rican | novel 4,5 |
8 | c.728_729insA | p.Ser244Phefs*4 | Exon 3 | Frameshift | Italian, Sicilian | (Boissy et al., 2005) 9 |
9 | c.851_852delGA | p.Arg284Lysfs*11 | Exon 3 | Indel | Portuguese | novel 5,11 |
10 | c.868C>T | p.Gln290* | Exon 3 | Nonsense | Arabic | (Khan et al., 2016) 7 |
11 | c.885–1G>A | IVS3–1G>A | Intron 3 | Splice site | Libyan | (Thielen et al., 2010) |
12 | c.1012G>T | p.Glu338* | Exon 5 | Nonsense | Caucasian | novel 5,12 |
13 | c.1107_1119del13insC | p.Pro370_Ser373del | Exon 5 | Indel | French-Canadian | novel 5,13,14 |
14 | c.1153_1160del8 | p.Val385Lysfs*2 | Exon 5 | Indel | Middle-Eastern | (Trujillano et al., 2017) 7 |
15 | c.1163+1G>A | IVS5+1G>A | Intron 5 | Splice site | Ashkenazi Jewish | (Huizing et al., 2001) |
16 | c.1189C>T | p.Arg397Trp | Exon 6 | Missense | Canadian, Caucasian, Chinese, German, Japanese, Polish, Russian, Swiss | (Huizing et al., 2001; Nazarian et al., 2008; Okamura et al., 2019; Wei et al., 2016) 7,12,15 |
17 | c.1195A>G/ c.1199_1200insATTGC | p.Ser399Gly/ p.Ala401Leufs*16 | Exon 6 | Indel | English, German, Irish, Scottish, Cherokee | novel 5,16 |
18 | c.1291delC | p.Leu431Phefs*3 | Exon 7 | Frameshift | Japanese | (Okamura et al., 2019) 7,8 |
19 | c.1426dupA | p.Ile476Asnfs*8 | Exon 8 | Frameshift | Japanese | (Saito et al., 2019) |
20 | c.1509G>A | p.Met503Ile | Exon 8 | Missense-Splice site | Pakistani | (Yousaf et al., 2016) 7,17 |
21 | c.1555_1595dup41 | p.Leu533Phefs*10 | Exon 8 | Indel | Chinese | (Power et al., 2019) |
22 | c.1673T>C | p.Leu558Pro | Exon 8 | Missense | - | (Lasseaux et al., 2018) 7 |
23 | c.1691+1G>A | IVS9+1G>A | Intron 9 | Splice site | French-Canadian | novel 5,13 |
24 | c.1691+2T>G | IVS9+2T>G | Intron 9 | Splice site | Ashkenazi Jewish | (Huizing et al., 2001) |
25 | c.1838C>G | p.Ser613* | Exon 10 | Nonsense | Chinese | (Wei et al., 2019) 7 |
26 | c.1870G>T | p.Glu624* | Exon 10 | Nonsense | German, Irish | novel 5,18 |
27 | c.2208_2209delTC | p.Gln737Alafs*20 | Exon 12 | Indel | Chinese | (Wei et al., 2016) 7 |
28 | c.2464C>T | p.Arg822* | Exon 13 | Nonsense | Dutch, German, Portuguese, Spanish | (Bastida et al., 2019) 6,7,11 |
29 | c.2482–2A>G | IVS13–2A>G | Intron 13 | Splice site | Irish/German | (Huizing et al., 2001) |
30 | c.2589+1G>C | IVS14+1G>C | Intron14 | Splice site | German/Swiss | (Huizing et al., 2001) |
31 | c.2589+1G>T | IVS14+1G>T | Intron14 | Splice site | German, Irish | novel 5,18 |
32 | c.2628delT | p.Ile877Phefs*25 | Exon 15 | Frameshift | - | (Lasseaux et al., 2018) 7 |
33 | c.2733delG | p.Leu912* | Exon 15 | Frameshift | English, German, Irish, Scottish, Cherokee | novel 5,16,19 |
34 | c.2739_2742delGAGA | p.Glu913Aspfs*14 | Exon 15 | Indel | - | novel 5,14 |
35 | c.2771delA | p.Asn924Ilefs*4 | Exon 15 | Frameshift | Turkish | (Sandrock-Lang et al., 2017) |
36 | c.2805G>A | p.Trp935* | Exon 16 | Nonsense | Chinese | (Wei et al., 2016) 7 |
37 | c.2888–1612G>A21 | IVS16–1612G>A p.Glu963Alafs*24 | Intron16 | Splice site | English, Irish | (Huizing et al., 2001) 20 |
When deletion/insertion is 1 nucleotide it is named Frame shift, when larger it is named Indel.
Extracted from literature reference. ‘-‘ = unreported.
This HPS3 3.9-kb deletion occurs within two Alu repeats, encompassing exon 1 and originates from a genetic isolate of central Puerto Rico (Anikster et al., 2001). Current nomenclature (as annotated in ClinVar) for this deletion is NM_032383.5(HPS3):c.-2993_217+692del or NC_000003.12:g.149126714_149130632del (GRCh38) or NG_009847.1:g.2131_6049del.
This HPS3 variant was identified in one unreported female subject of Puerto Rican descent in the NIH cohort. This subject was compound heterozygous for c.726delinsTGCCTTACATC and the Central Puerto Rican founder variant g.del3.9-kb.
novel = previously unreported variant detected in the NIH HPS cohort.
This HPS3 variant was identified in one unreported male subject of Dutch-German descent in the NIH HPS cohort. This subject was compound heterozygous for c.15C>G and c.2464C>T.
At least one of the reported cases with this variant was identified by next generation sequencing.
The HPS3 variant c.437_439delGAG occurred compound heterozygous with c.1291delC in a subject of Japanese descent who also had non-segmental vitiligo (Okamura et al., 2019).
This HPS3 variant c.728insA was identified homozygous in one unreported female subject of Sicilian decent in the NIH HPS cohort.
Gray highlight: missense variant. See Supplemental Table S1 for pathogenicity description.
This HPS3 variant was identified in one unreported male subject of Portuguese decent in the NIH HPS cohort. This subject was compound heterozygous for c.851_852delGA and c.2464C>T.
This HPS3 variant was identified in one unreported female subject of Caucasian descent in the NIH HPS cohort. This subject was compound heterozygous for c.1012G>T and c.1189C>T.
This HPS3 variant was identified in one unreported female subject of French-Canadian descent in the NIH HPS cohort. This subject was compound heterozygous for c.1107_1119del13insC and c.1691+1G>A.
This HPS3 variant was identified in one unreported female subject of in the NIH cohort (referred by Dr. Doherty, Carilion Clinic, Roanoke, VA). This subject was compound heterozygous for c.1107_1119del13insC and c.2739_2742delGAGA.
This HPS3 variant c.1189C>T was identified homozygous in one unreported female subject of Canadian-Polish-Russian decent in the NIH cohort. Cells of this patient showed destabilized BLOC-2 assembly, likely due to pathogenicity of this variant (Nazarian et al., 2008).
This HPS3 variant was identified in one unreported female subject of English-German-Irish-Scottish-Cherokee descent in the NIH HPS cohort. This subject was compound heterozygous for c.1195A>G/1199insATTGC and c.2733delG.
This (missense) HPS3 variant c.1509G>A; p.Met503Ile occurs at the exon8/intron 8 splice site junction and may affect splicing. This variant occurs homozygous in 4 subjects of a consanguineous Pakistani family (Yousaf et al., 2016).
This HPS3 variant was identified in one unreported male subject of German-Irish descent. This subject was compound heterozygous for c.1870G>T and c.2589+1G>T.
Subject HPS34 of English-Irish descent in (Huizing et al., 2001) was reported heterozygous for c.2887+2500G>A. We found c.2733delG to be the second HPS3 variant in this subject.
This HPS3 variant was reported in an alternative nomenclature as c.2887+2500G>A. This intronic variant introduces a new consensus splice site that results in insertion of 89-bp (a ‘pseudoexon’) in the patient’s cDNA (Huizing et al., 2001; Vorechovsky, 2010).